Skip to main content
Erschienen in: Obesity Surgery 5/2016

05.09.2015 | Original Contributions

Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy

verfasst von: Lindsay B. Adams, Craig Chang, Janet Pope, Yeonsoo Kim, Pei Liu, Amy Yates

Erschienen in: Obesity Surgery | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Several studies have examined the role of ursodeoxycholic acid (UDCA) for the prevention of cholelithiasis (gallstones) following rapid weight loss from restrictive diets, vertical band gastroplasty, and Roux-en-Y gastric bypass. However, to date, there have been no prospective, controlled studies examining the role of UDCA for the prevention of gallstones following sleeve gastrectomy (SG). This study was conducted to identify the effectiveness of UDCA for prevention of gallstones after SG.

Methods

Following SG, eligible patients were randomized to a control group who did not receive UDCA treatment or to a group who were prescribed 300 mg UDCA twice daily for 6 months. Gallbladder ultrasounds were performed preoperatively and at 6 and 12 months postoperatively. Patients with positive findings preoperatively were excluded from the study. Compliance with UDCA was assessed.

Results

Between December 2011 and April 2013, 37 patients were randomized to the UDCA treatment arm and 38 patients were randomized to no treatment. At baseline, the two groups were similar. At 6 months, the UDCA group had a statistically significant lower incidence of gallstones (p = 0.032). Analysis revealed no significant difference in gallstones between the two groups at 1 year (p = 0.553 and p = 0.962, respectively). The overall gallstone formation rate was 29.8 %.

Conclusions

The incidence of gallstones is higher than previously estimated in SG patients. UDCA significantly lowers the gallstone formation rate at 6 months postoperatively.
Literatur
1.
Zurück zum Zitat Lewis CE, Dhanasopon A, Dutson EP, et al. Early experience with laparoscopic sleeve gastrectomy as a single-stage bariatric procedure. Am Surg. 2009;75:945–49.PubMed Lewis CE, Dhanasopon A, Dutson EP, et al. Early experience with laparoscopic sleeve gastrectomy as a single-stage bariatric procedure. Am Surg. 2009;75:945–49.PubMed
2.
Zurück zum Zitat Nguyen NT, Nguyen B, Gebhart A, et al. Changes in the makeup of bariatric surgery: a national increase in use of laparoscopic sleeve gastrectomy. J Am Coll Surg. 2013;216:252–57.CrossRefPubMed Nguyen NT, Nguyen B, Gebhart A, et al. Changes in the makeup of bariatric surgery: a national increase in use of laparoscopic sleeve gastrectomy. J Am Coll Surg. 2013;216:252–57.CrossRefPubMed
3.
Zurück zum Zitat Abbatini F, Rizzello M, Casella G, et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc. 2010;24:1005–10.CrossRefPubMed Abbatini F, Rizzello M, Casella G, et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc. 2010;24:1005–10.CrossRefPubMed
4.
Zurück zum Zitat Lee CM, Cirangle PT, Jossart GH. Vertical gastrectomy in 216 patients: report of two-year results. Surg Endosc. 2007;21:1810–16.CrossRefPubMed Lee CM, Cirangle PT, Jossart GH. Vertical gastrectomy in 216 patients: report of two-year results. Surg Endosc. 2007;21:1810–16.CrossRefPubMed
5.
Zurück zum Zitat Roa PE, Kaaidar- Person O, Pinto D, et al. Laparascopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg. 2006;16:1323–26.CrossRefPubMed Roa PE, Kaaidar- Person O, Pinto D, et al. Laparascopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg. 2006;16:1323–26.CrossRefPubMed
6.
Zurück zum Zitat Brandao I, de Oliveira C, Adami Chaim E, et al. Impact of rapid weight reduction on risk of cholelithiasis after bariatric surgery. Obes Surg. 2003;13:625–8.CrossRef Brandao I, de Oliveira C, Adami Chaim E, et al. Impact of rapid weight reduction on risk of cholelithiasis after bariatric surgery. Obes Surg. 2003;13:625–8.CrossRef
7.
Zurück zum Zitat Abo-Ryia MH, Abd-Allah HS, El-Khadrawy OH, et al. Predictors of gallstone formation in morbidly obese patients after bariatric surgery: a retrospective observational study. Surg Sci. 2014;5:1–5.CrossRef Abo-Ryia MH, Abd-Allah HS, El-Khadrawy OH, et al. Predictors of gallstone formation in morbidly obese patients after bariatric surgery: a retrospective observational study. Surg Sci. 2014;5:1–5.CrossRef
8.
Zurück zum Zitat Li VKM, Pulido N, Fajnwaks P, et al. Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy. Surg Endosc. 2009;23:1640–44.CrossRefPubMed Li VKM, Pulido N, Fajnwaks P, et al. Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy. Surg Endosc. 2009;23:1640–44.CrossRefPubMed
9.
Zurück zum Zitat Sioka E, Zacharoulis D, Zachari E, Papamargaritis D, Pinaka O, Katsogridaki G, et al. Complicated gallstones after laparoscopic sleeve gastrectomy. J Obes. 2014;468203 Sioka E, Zacharoulis D, Zachari E, Papamargaritis D, Pinaka O, Katsogridaki G, et al. Complicated gallstones after laparoscopic sleeve gastrectomy. J Obes. 2014;468203
10.
Zurück zum Zitat Villegas L, Schneider B, Provost D, et al. Is routine cholecystectomy required during laparoscopic gastric bypass? Obes Surg. 2004;14(2):206–11.CrossRefPubMed Villegas L, Schneider B, Provost D, et al. Is routine cholecystectomy required during laparoscopic gastric bypass? Obes Surg. 2004;14(2):206–11.CrossRefPubMed
11.
Zurück zum Zitat Sugerman HJ, Brewer WH, Shiffman ML, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg. 1995;169(1):91–6.CrossRefPubMed Sugerman HJ, Brewer WH, Shiffman ML, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg. 1995;169(1):91–6.CrossRefPubMed
12.
Zurück zum Zitat Williams CN, Gowan R, Perey BJ. A double-blind placebo-controlled trial of ursodeoxycholic acid in the prevention of gallstones during weight loss after vertical band gastroplasty. Obes Surg. 1993;3:257–9.CrossRefPubMed Williams CN, Gowan R, Perey BJ. A double-blind placebo-controlled trial of ursodeoxycholic acid in the prevention of gallstones during weight loss after vertical band gastroplasty. Obes Surg. 1993;3:257–9.CrossRefPubMed
13.
Zurück zum Zitat Worobetz LJ, Inglis FG, Shaffer EA. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss. Am J Gastroenterol. 1993;88(10):1705–10.PubMed Worobetz LJ, Inglis FG, Shaffer EA. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss. Am J Gastroenterol. 1993;88(10):1705–10.PubMed
14.
Zurück zum Zitat Miller K, Hell E, Lang B, et al. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss. Ann Surg. 2003;238:697–702.CrossRefPubMedPubMedCentral Miller K, Hell E, Lang B, et al. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss. Ann Surg. 2003;238:697–702.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Gourash WF, Ebel F, Lancaster K, et al. Longitudinal assessment of bariatric surgery (LABS): retention strategy and results at 24 months. Surg Obes Relat Dis. 2013;9:514–9.CrossRefPubMed Gourash WF, Ebel F, Lancaster K, et al. Longitudinal assessment of bariatric surgery (LABS): retention strategy and results at 24 months. Surg Obes Relat Dis. 2013;9:514–9.CrossRefPubMed
16.
Zurück zum Zitat Shiffman ML, Shamburek RD, Schwartz CC, et al. Gallbladder mucin, arachidonic acid, and bile lipids in patients who develop gallstones during weight reduction. Gastroenterology. 1993;105:1200–8.PubMed Shiffman ML, Shamburek RD, Schwartz CC, et al. Gallbladder mucin, arachidonic acid, and bile lipids in patients who develop gallstones during weight reduction. Gastroenterology. 1993;105:1200–8.PubMed
17.
Zurück zum Zitat Jamal M, Wegner R, Heitshusen D, et al. Resolution of hyperlipidemia follows surgical weight loss in patients undergoing Roux-en-Y gastric bypass surgery: a 6 year analysis of data. Surg Obes Rel Dis. 2011;7:473–79.CrossRef Jamal M, Wegner R, Heitshusen D, et al. Resolution of hyperlipidemia follows surgical weight loss in patients undergoing Roux-en-Y gastric bypass surgery: a 6 year analysis of data. Surg Obes Rel Dis. 2011;7:473–79.CrossRef
18.
Zurück zum Zitat Vix M, Diana M, Liu KH, et al. Evolution of glycolipid profile after sleeve gastrectomy vs. Roux-en-Y gastric bypass: results of a prospective randomized clinical trial. Obes Surg. 2013;23:613–21.CrossRefPubMed Vix M, Diana M, Liu KH, et al. Evolution of glycolipid profile after sleeve gastrectomy vs. Roux-en-Y gastric bypass: results of a prospective randomized clinical trial. Obes Surg. 2013;23:613–21.CrossRefPubMed
19.
Zurück zum Zitat Reuben A, Qureshi Y, Murphy GM, et al. Effect of obesity and weight reduction on biliary cholesterol saturation and the response to chenodeoxycholic acid. Eur J Clin Invest. 1986;16:133–42.CrossRefPubMed Reuben A, Qureshi Y, Murphy GM, et al. Effect of obesity and weight reduction on biliary cholesterol saturation and the response to chenodeoxycholic acid. Eur J Clin Invest. 1986;16:133–42.CrossRefPubMed
20.
Zurück zum Zitat Schlierf G, Schellenberg B, Stiehl A, et al. Biliary cholesterol saturation and weight reduction-effects of fasting and low calorie diet. Digestion. 1981;21:44–9.CrossRefPubMed Schlierf G, Schellenberg B, Stiehl A, et al. Biliary cholesterol saturation and weight reduction-effects of fasting and low calorie diet. Digestion. 1981;21:44–9.CrossRefPubMed
21.
Zurück zum Zitat Marzio L, Capone F, Neri M, et al. Gallbladder kinetics in obese patients: effect of a regular meal and low-calorie meal. Dig Dis Sci. 1988;22:4–9.CrossRef Marzio L, Capone F, Neri M, et al. Gallbladder kinetics in obese patients: effect of a regular meal and low-calorie meal. Dig Dis Sci. 1988;22:4–9.CrossRef
22.
Zurück zum Zitat Fisher RS, Rock E, Malmud LS. Effects of meal composition on gallbladder and gastric emptying in man. Dig Dis Sci. 1987;32:1337–44.CrossRefPubMed Fisher RS, Rock E, Malmud LS. Effects of meal composition on gallbladder and gastric emptying in man. Dig Dis Sci. 1987;32:1337–44.CrossRefPubMed
23.
Zurück zum Zitat Thompson RS, Rivara FP, Thompson DC. Ursodeoxycholic acid and gallstones during weight loss. N Engl J Med. 1989;320:1351–53.CrossRef Thompson RS, Rivara FP, Thompson DC. Ursodeoxycholic acid and gallstones during weight loss. N Engl J Med. 1989;320:1351–53.CrossRef
24.
Zurück zum Zitat Stone BG, Ansel HJ, Peterson FJ, et al. Gallbladder emptying stimuli in obese and normal-weight subjects. Hepatology. 1992;15:795–9.CrossRefPubMed Stone BG, Ansel HJ, Peterson FJ, et al. Gallbladder emptying stimuli in obese and normal-weight subjects. Hepatology. 1992;15:795–9.CrossRefPubMed
25.
Zurück zum Zitat D’Hondt M, Sergeant G, Deylgat B, et al. Prophylactic cholecystectomy, a mandatory step in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass? J Gastrointest Surg. 2011;5:1532–36.CrossRef D’Hondt M, Sergeant G, Deylgat B, et al. Prophylactic cholecystectomy, a mandatory step in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass? J Gastrointest Surg. 2011;5:1532–36.CrossRef
26.
Zurück zum Zitat Quesada BM, Kohan G, Roff HE, et al. Management of gallstones and gallbladder disease in patients undergoing gastric bypass. World J Gastroenterol. 2010;16:2075–79.CrossRefPubMedPubMedCentral Quesada BM, Kohan G, Roff HE, et al. Management of gallstones and gallbladder disease in patients undergoing gastric bypass. World J Gastroenterol. 2010;16:2075–79.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Li VKM, Pulido N, Martinez-Suartez P, et al. Symptomatic gallstones after sleeve gastrectomy. Surg Endosc. 2009;23:2488–92.CrossRefPubMed Li VKM, Pulido N, Martinez-Suartez P, et al. Symptomatic gallstones after sleeve gastrectomy. Surg Endosc. 2009;23:2488–92.CrossRefPubMed
28.
Zurück zum Zitat Miller K, Hell E, Lang B, et al. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial. Ann Surg. 2003;238:697–70.CrossRefPubMedPubMedCentral Miller K, Hell E, Lang B, et al. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial. Ann Surg. 2003;238:697–70.CrossRefPubMedPubMedCentral
Metadaten
Titel
Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy
verfasst von
Lindsay B. Adams
Craig Chang
Janet Pope
Yeonsoo Kim
Pei Liu
Amy Yates
Publikationsdatum
05.09.2015
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 5/2016
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-015-1858-5

Weitere Artikel der Ausgabe 5/2016

Obesity Surgery 5/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.